The real-world evidence revolution: Finding value and relevance through the stakeholder perspective

January 19, 2017 Christoph Graener

We are seeing rapid progress in biomedicine, from inexpensive whole genome sequencing, to Big Data analytics, to bioengineering feats. But the next big innovation may not be in the lab. The critical research biopharma organizations are increasingly leveraging falls along the lines of database analyses, prospective observational studies and knowledge gleaned from interviews with all stakeholders.

Moderator: David Thompson – inVentiv Health

  • Wade Ackerman – Covington & Burling LLP
  • Ted Haack – LatticePoint Consulting
  • Jamie Heywood – PatientsLikeMe
  • Philippe Lopes-Fernandes – EMD Serono
  • Steve Wooding – Janssen Pharmaceutical Companies of Johnson & Johnson

Previous Article
State of the Digital Medicine Industry

Tools that will usher in a new age of healthcare are changing the game by creating more effective R&D proce...

Next Article
Consumer products give new life to pharma
Consumer products give new life to pharma

The relevance of the consumer isn’t a new condition, but the role consumers play as companies make product ...